ep beat compar estim ex-tax repatri
better revenu higher profit trend factor line ad
note sbc account chang ad consist
previou estim rais ep
ep reflect latest momentum
account chang favor fx tp move
higher view
organ revenu impress revenu exceed
stronger organ growth vs estimate
vs driven us ou
acceler consum line rapid vs
ref lab vs bp day impact slightli
plan instrument revenu line place sedivu
vs estimate experienc spike core catalyst albeit
rel easi compar gross margin fell bp
bp plan higher lpd/water cost lower instrument
margin oper expens declin bp contribut ebit
margin expans bp flow million facilit
continu share repurchas reserv stand million
momentum share continu increment encourag
upsid higher guidanc target acceler
organ revenu growth includ asu
continu expect underli oper margin expans
instrument placement bright spot competit catalyst
placement impress well ahead closest competitor
underscor execut date direct strategi also
encourag strength recur revenu vs
point sustain momentum vet demand view well
posit robust fundament backdrop driver innov
grow instal base geograph expans fuel organ
growth doubl digit ep growth next five year ahead
industri risk includ shift fundament demand competit landscap
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
global leader diagnost point-of-car equip
refer laboratori servic companion anim also
provid system diagnost livestock water qualiti
price jan rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
gain refer laboratori point-of-car acceler global
expans greater contribut innov new product
launch technolog advanc greater expect
growth broader anim health industri fundament
stronger expect macroeconom fx headwind
increasingli global footprint less adoption/tract futur product
launch deterior veterinari health fundament
competit account
competit account
compani mention price
